David Cameron
See all articles with this subject.
-
CommentThe Bedpan: David Cameron’s autobiography
The Bedpan examines the views of influential figures from (usually) outside the health world who nevertheless have interesting views on the challenges facing the NHS. It is named after Nye Bevan’s apocryphal quote.
-
Comment
Cowper's Cut: Why Ian Dalton and Matthew Swindells really got the bullet
Andy Cowper discusses the recent appointment of Simon Stevens as the chief of both NHS Improvement and England
-
Comment
Cowper’s Cut: A brief history of NHS plans
With the release of the 10 Year Forward View imminent, Andy Cowper reflects on the success of the various NHS plans published in the last two decades and what to expect from the 10YFV
-
Expert Briefing
The Download: New challenger in the GP tech goldrush
The fortnightly newsletter that unpacks system leaders’ priorities for digital technology and the impact they are having on delivering health services. Contact Ben Heather in confidence here.
-
News
Who is Matt Hancock?
Matt Hancock will head the Department of Health and Social Care after Jeremy Hunt - the longest serving health secretary in history - was moved to the Foreign Office. But who is Matt Hancock?
-
Comment
Cowper’s Cut: Mandatory guidance
Empowering patients and offering greater choice are good things – they are just not free good things, writes Andy Cowper
-
Comment
Cowper’s Cut: Towards good ideas
Even as Jeremy Hunt and Philip Hammond argue over the budget boost for the NHS, other people are starting to have some good ideas about helping out the NHS, writes Andy Cowper
-
Comment
Cowper’s Cut: Absolutely nobody has a plan (Don’t panic, Captain Mainwaring!)
Andy Cowper opines that currently no one has a plan for the NHS and even though it is scary it is OK
-
Comment
Cowper’s Cut: Politics, game theory and Belgian lessons
Andy Cowper gives the lowdown on the ups and downs of British politics, which influences the funding available to the NHS
-
News
Flagship cancer fund underspent amid uncertainty over its future
NHS England’s flagship cancer drugs fund had spent just over a quarter of its budget halfway through this financial year, amid questions over its long term future.
